Adaptive Naming Treatment Schedules for Aphasia
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that using retrieval practice (practicing recalling names) and spacing (spreading out practice sessions) improves naming abilities in people with aphasia. These methods have been found to be more effective than simple repetition, suggesting that the adaptive treatment schedules could be beneficial for improving naming skills.
12345The research articles provided do not contain specific safety data for the Adaptive Naming Treatment or its variations. They focus on the effectiveness of different treatment approaches for naming deficits in aphasia.
24567The Adaptive Naming Treatment for Aphasia is unique because it uses adaptive spacing, which adjusts the timing between practice sessions based on the patient's performance, to enhance learning and retention of word naming. This approach contrasts with traditional methods that use fixed or random intervals, and it incorporates retrieval practice, which has been shown to be more effective than simple repetition in improving naming abilities.
12345Eligibility Criteria
This trial is for people who have had a stroke leading to aphasia, a language disorder, and struggle with finding words. They must be at least six months post-stroke, show specific difficulties on the Comprehensive Aphasia Test, and can use telehealth services via high-speed internet. It's not for those with other neurological diseases, severe comprehension issues, uncontrolled substance dependence or serious mood disorders.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 weeks of computer-based training per condition, including one-on-one and independent practice sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment with probes administered at baseline and at 1 week, 3 months, and 6 months post-treatment
Participant Groups
Adaptive Spacing Condition is already approved in United States for the following indications:
- Aphasia
- Anomia